GlassScriptPhysician profile
Sayed F Feghali
NPI 1326040486
$4,471.72
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,179 · 2020: $631 · 2021: $1,203 · 2022: $1,111 · 2023: $287 · 2024: $60.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $909.94 | 2019-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $352.76 | 2019-2022 | |
| Esperion Therapeutics, INC. | $335.30 | 2020-2022 | |
| Amarin Pharma, INC. | $329.33 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $327.14 | 2019-2022 | |
| Novo Nordisk INC | $315.20 | 2022-2023 | Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $218.44 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $191.33 | 2022-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.53 | 2019-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $139.39 | 2019-2021 | |
| Abiomed | $131.05 | 2022 | |
| Pfizer INC. | $125.88 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $125.42 | 2019-2022 | |
| Heartflow, INC. | $125.00 | 2021 | |
| Abbott Laboratories | $115.26 | 2020-2024 | Diamondback Peripheral |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $110.65 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $91.92 | 2022-2023 | Opsumit |
| Kowa Pharmaceuticals America, INC. | $73.92 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $47.14 | 2019-2021 | |
| Boston Scientific Corporation | $44.95 | 2020-2023 | Ekosonic |
| Ethicon US, LLC | $43.86 | 2023 | Surgicel Nu-Knit |
| Irhythm Technologies, INC. | $24.22 | 2023 | Zio Xt Patch |
| Astellas Pharma US INC | $21.56 | 2021 | |
| Medtronic Vascular, INC. | $19.59 | 2020 | |
| Allergan, INC. | $17.81 | 2019 | |
| Aimmune Therapeutics, INC. | $17.42 | 2022 | |
| Lundbeck LLC | $15.92 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.53 | 2019 | |
| Avinger INC. | $15.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sayed Feghali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.